Perphenazine
Perphenazine is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Perphenazine; Generic name: PERPHENAZINE; Drug class: Phenothiazine [EPC].
| Brand name | Perphenazine |
|---|---|
| Generic name | PERPHENAZINE |
| Drug class | Phenothiazine [EPC] |
| Manufacturer | Major Pharmaceuticals |
| Used for | INDICATIONS AND USAGE Perphenazine is indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults. Perphenazine has not been shown effective for the management of behavioral complications in patients with mental retardation. |
| Dosage | DOSAGE AND ADMINISTRATION Dosage must be individualized and adjusted according to the severity of the condition and the response obtained. As with all potent drugs, the best dose is the lowest dose that will produce the desired clinical effect. Since extrapyramidal symptoms increase in frequency and severity with increased dosage, it is important to employ the lowest effective dose. These symptoms have disappeared upon reduction of dosage, withdrawal of the drug, or administration of an antipark |
| Warnings | WARNINGS Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Perphenazine is not approved for the treatment of patients with dementia-related psychosis (see BOXED WARNING ). Tardive dyskinesia, a syndrome consisting of potentially irreversible, involuntary, dyskinetic movements, may develop in patients treated with antipsychotic drugs. Older patients are at inc |
| Active ingredient(s) | PERPHENAZINE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0dc77ea9-32ee-4b6d-b69d-8c712bcf5fe4 |